| Clinical features, long-term follow-up and outcome of a large cohort of patients with chronic granulomatous disease: an Italian multicenter study B Martire, R Rondelli, A Soresina, C Pignata, T Broccoletti, A Finocchi, ... Clinical immunology 126 (2), 155-164, 2008 | 386 | 2008 |
| Treatment strategies for multiple sclerosis: When to start, when to change, when to stop? A Gajofatto, MD Benedetti | 343 | 2015 |
| Inflammatory intrathecal profiles and cortical damage in multiple sclerosis R Magliozzi, OW Howell, R Nicholas, C Cruciani, M Castellaro, ... Annals of neurology 83 (4), 739-755, 2018 | 289 | 2018 |
| Clinical spectrum and IgG subclass analysis of anti-myelin oligodendrocyte glycoprotein antibody-associated syndromes: a multicenter study S Mariotto, S Ferrari, S Monaco, MD Benedetti, K Schanda, D Alberti, ... Journal of neurology 264, 2420-2430, 2017 | 161 | 2017 |
| HCV‐related nervous system disorders S Monaco, S Ferrari, A Gajofatto, G Zanusso, S Mariotto Journal of Immunology Research 2012 (1), 236148, 2012 | 144 | 2012 |
| Hepatitis C virus-associated neurocognitive and neuropsychiatric disorders: Advances in 2015 S Monaco, S Mariotto, S Ferrari, M Calabrese, G Zanusso, A Gajofatto, ... World Journal of Gastroenterology 21 (42), 11974, 2015 | 142 | 2015 |
| Switching first-line disease-modifying therapy after failure: impact on the course of relapsing–remitting multiple sclerosis A Gajofatto, P Bacchetti, B Grimes, A High, E Waubant Multiple Sclerosis Journal 15 (1), 50-58, 2009 | 127 | 2009 |
| DMTs and Covid‐19 severity in MS: a pooled analysis from Italy and France MP Sormani, M Salvetti, P Labauge, I Schiavetti, H Zephir, L Carmisciano, ... Annals of Clinical and Translational Neurology 8 (8), 1738-1744, 2021 | 119 | 2021 |
| Increased cortical lesion load and intrathecal inflammation is associated with oligoclonal bands in multiple sclerosis patients: a combined CSF and MRI study G Farina, R Magliozzi, M Pitteri, R Reynolds, S Rossi, A Gajofatto, ... Journal of neuroinflammation 14, 1-11, 2017 | 117 | 2017 |
| Efficacy and safety of cannabinoid oromucosal spray for multiple sclerosis spasticity F Patti, S Messina, C Solaro, MP Amato, R Bergamaschi, S Bonavita, ... Journal of Neurology, Neurosurgery & Psychiatry 87 (9), 944-951, 2016 | 117 | 2016 |
| Clinical, MRI, and CSF markers of disability progression in multiple sclerosis A Gajofatto, M Calabrese, MD Benedetti, S Monaco Disease markers 35 (6), 687-699, 2013 | 116 | 2013 |
| Sensory integration balance training in patients with multiple sclerosis: a randomized, controlled trial M Gandolfi, D Munari, C Geroin, A Gajofatto, MD Benedetti, A Midiri, ... Multiple Sclerosis Journal 21 (11), 1453-1462, 2015 | 113 | 2015 |
| Relevance of antibodies to myelin oligodendrocyte glycoprotein in CSF of seronegative cases S Mariotto, A Gajofatto, L Batzu, R Delogu, GP Sechi, S Leoni, MI Pirastru, ... Neurology 93 (20), e1867-e1872, 2019 | 103 | 2019 |
| Neurological complications of HIV infection in pre-HAART and HAART era: a retrospective study A Matinella, M Lanzafame, MA Bonometti, A Gajofatto, E Concia, S Vento, ... Journal of Neurology 262, 1317-1327, 2015 | 99 | 2015 |
| Epstein-Barr virus lytic infection promotes activation of Toll-like receptor 8 innate immune response in systemic sclerosis monocytes A Farina, G Peruzzi, V Lacconi, S Lenna, S Quarta, E Rosato, AR Vestri, ... Arthritis research & therapy 19, 1-14, 2017 | 90 | 2017 |
| Prognostic value of multimodal evoked potentials in multiple sclerosis: the EP score P Invernizzi, L Bertolasi, MR Bianchi, M Turatti, A Gajofatto, MD Benedetti Journal of neurology 258, 1933-1939, 2011 | 90 | 2011 |
| mRNA COVID-19 vaccines do not increase the short-term risk of clinical relapses in multiple sclerosis M Di Filippo, C Cordioli, S Malucchi, P Annovazzi, P Cavalla, VT Clerici, ... Journal of Neurology, Neurosurgery & Psychiatry 93 (4), 448-450, 2022 | 73 | 2022 |
| Regional distribution and evolution of gray matter damage in different populations of multiple sclerosis patients M Calabrese, R Reynolds, R Magliozzi, M Castellaro, A Morra, A Scalfari, ... PloS one 10 (8), e0135428, 2015 | 70 | 2015 |
| Switching multiple sclerosis patients with breakthrough disease to second-line therapy T Castillo-Trivino, EM Mowry, A Gajofatto, D Chabas, E Crabtree-Hartman, ... PloS one 6 (2), e16664, 2011 | 66 | 2011 |
| Assessment of outcome predictors in first-episode acute myelitis: a retrospective study of 53 cases A Gajofatto, S Monaco, M Fiorini, G Zanusso, M Vedovello, F Rossi, ... Archives of neurology 67 (6), 724-730, 2010 | 63 | 2010 |
